Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | CD44 | P16070 | 1/20 | 0.36 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3439540 | 0.87 | ALDH1A1 (0.53) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| Hydrochloric Acid SCHEMBL10903841 | 0.85 | ALDH1A1 (0.50) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| SCHEMBL6765257 | 0.85 | ALDH1A1 (0.56) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| SCHEMBL3341004 | 0.81 | ALDH1A1 (0.46) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| SCHEMBL30052666 | 0.79 | ALDH1A1 (0.43) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| SCHEMBL16372580 | 0.79 | TUBB4A (0.49) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| SCHEMBL11848358 | 0.79 | ALDH1A1 (0.43) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| SCHEMBL12290391 | 0.79 | ALDH1A1 (0.43) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| SCHEMBL16134065 | 0.77 | ALDH1A1 (0.42) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| SCHEMBL16134068 | 0.77 | ALDH1A1 (0.42) | ALDH1A1MEN1MAPTTHRBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331710-A1 | HETEROCYCLIC COMPOUND, PREPARATION METHOD AND USE THEREOF | SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO. LTD (CN) | 2023-10-19 | — | — | US | disclosed |
| US-20230331710-A1 | HETEROCYCLIC COMPOUND, PREPARATION METHOD AND USE THEREOF | SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO. LTD (CN) | 2023-10-19 | — | — | US | disclosed |
| US-20230331710-A1 | HETEROCYCLIC COMPOUND, PREPARATION METHOD AND USE THEREOF | SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO. LTD (CN) | 2023-10-19 | — | — | US | disclosed |
| CN-114057692-B | Heterocyclic compound, preparation method and application thereof | 上海美悦生物科技发展有限公司 | 2023-07-21 | — | — | CN | disclosed |
| EP-4194449-A1 | HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Meiyue Biotech Development Co., Ltd. (CN) | 2023-06-14 | — | — | EP | disclosed |
| EP-4194449-A1 | HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Meiyue Biotech Development Co., Ltd. (CN) | 2023-06-14 | — | — | EP | disclosed |
| CN-114057692-A | Heterocyclic compound, preparation method and application thereof | 上海美悦生物科技发展有限公司 | 2022-02-18 | — | — | CN | disclosed |
| CN-1754108-A | Method for producing article having been subjected to low reflection treatment, solution for forming low reflection layer and article having been subjected to low reflection treatment | SDC TECH ASIA CO LTD (JP) | 2006-03-29 | — | — | CN | disclosed |
| EP-1290089-A2 | SOFT POLYMER COMPOSITION INCLUDING EPOXY | Bridgestone Corporation (JP) | 2003-03-12 | — | — | EP | disclosed |
| EP-1287068-A2 | SOFT POLYMER GEL | Bridgestone Corporation (JP) | 2003-03-05 | — | — | EP | disclosed |
| WO-2001094467-A2 | SOFT POLYMER COMPOSITION INCLUDING EPOXY | BRIDGESTONE CORPORATION (JP) | 2001-12-13 | — | — | WO | disclosed |
| WO-2001094465-A2 | SOFT POLYMER GEL | BRIDGESTONE CORPORATION (JP) | 2001-12-13 | — | — | WO | disclosed |
| US-3953452-A | Perinone dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331710-A1 | HETEROCYCLIC COMPOUND, PREPARATION METHOD AND USE THEREOF | C9, CFB, C5 | ALDH1A1 3003/4885MEN1 377/4885MAPT 3796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.